348 related articles for article (PubMed ID: 11474023)
21. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Pfaller MA; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
[TBL] [Abstract][Full Text] [Related]
22. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the colorimetric VITEK 2 card for identification of gram-negative nonfermentative rods: comparison to 16S rRNA gene sequencing.
Zbinden A; Böttger EC; Bosshard PP; Zbinden R
J Clin Microbiol; 2007 Jul; 45(7):2270-3. PubMed ID: 17507509
[TBL] [Abstract][Full Text] [Related]
25. Validation of Vitek 2 nonfermenting gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting gram-negative rods from patients with cystic fibrosis.
Otto-Karg I; Jandl S; Müller T; Stirzel B; Frosch M; Hebestreit H; Abele-Horn M
J Clin Microbiol; 2009 Oct; 47(10):3283-8. PubMed ID: 19710272
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
Korten V; Ulusoy S; Zarakolu P; Mete B;
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli.
O'Hara CM
J Clin Microbiol; 2006 Mar; 44(3):928-33. PubMed ID: 16517878
[TBL] [Abstract][Full Text] [Related]
28. Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.
Menozzi MG; Eigner U; Covan S; Rossi S; Somenzi P; Dettori G; Chezzi C; Fahr AM
J Clin Microbiol; 2006 Nov; 44(11):4085-94. PubMed ID: 17005752
[TBL] [Abstract][Full Text] [Related]
29. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates.
Turner PJ
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):217-22. PubMed ID: 19070453
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
31. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007.
Guembe M; Cercenado E; Alcalá L; Marín M; Insa R; Bouza E
Rev Esp Quimioter; 2008 Sep; 21(3):166-73. PubMed ID: 18792817
[TBL] [Abstract][Full Text] [Related]
32. Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results.
Turner PJ
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):185-92. PubMed ID: 17945455
[TBL] [Abstract][Full Text] [Related]
33. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
[TBL] [Abstract][Full Text] [Related]
34. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Streit JM; Jones RN; Sader HS; Fritsche TR
Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
[TBL] [Abstract][Full Text] [Related]
35. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory.
Bosshard PP; Zbinden R; Abels S; Böddinghaus B; Altwegg M; Böttger EC
J Clin Microbiol; 2006 Apr; 44(4):1359-66. PubMed ID: 16597863
[TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates.
Gherardi G; Angeletti S; Panitti M; Pompilio A; Di Bonaventura G; Crea F; Avola A; Fico L; Palazzo C; Sapia GF; Visaggio D; Dicuonzo G
Diagn Microbiol Infect Dis; 2012 Jan; 72(1):20-31. PubMed ID: 22030102
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
[TBL] [Abstract][Full Text] [Related]
38. Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System.
Endimiani A; Luzzaro F; Tamborini A; Lombardi G; Elia V; Belloni R; Toniolo A
New Microbiol; 2002 Jul; 25(3):323-9. PubMed ID: 12173774
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci.
Yamazumi T; Furuta I; Diekema DJ; Pfaller MA; Jones RN
J Clin Microbiol; 2001 Oct; 39(10):3633-6. PubMed ID: 11574584
[TBL] [Abstract][Full Text] [Related]
40. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
